This review summarizes the recent development on metalloporphyrin catalyzed biomimetic oxidations as applied for modeling cytochrome P450 mediated oxidative metabolic processes. Successful applications of metalloporphyrin-based models on known drugs, drug candidates and agrochemicals were reviewed.
Introduction
Cytochrome P450 is a member of the monoxygenase family of heme enzymes that plays an important role in metabolizing biomolecules and xenobiotics. The mechanism of its catalytic activity and structural functions have been the subject of extensive investigation in the field of biomimetic chemistry. The high-valent iron(IV)-oxo intermediate, formed by the reductive activation of molecular oxygen via peroxo-iron(III) and hydroperoxy-iron(III) intermediates by cytochrome P450, 1 is responsible for the in vivo oxidation of drugs and xenobiotics. This highvalent iron(IV)-oxo intermediate and probably other intermediates of the P450 catalytic cycle can be formed by the reaction of iron(III) porphyrins with different monooxygen donors and are responsible for the hydroxylation of hydrocarbons, epoxidation of olefins, oxidation of heteroatoms and the cleavage of C-C bonds in organic substrates. Although there are no any difference the activation state of the mainly used first row transition metalloporphyrins (Fe 2+ or Mn 2+ centered), difference of their substrate specificity and region selectivity was verified.
Moreover the mainly used second row transition metal porphyrin complexes ruthenium (II) react with oxygen donors resulting trans-dioxo species which are mainly used for specific epoxidations of olefins. Besides of mechanistic studies these metalloporphyrin-based systems ( Figure 1 ) can be used for the investigation of metabolic reactions of different substrates. 2 The advantages of using model system to understand drug metabolism are as follows:
• chemical oxidations performed by biomimetic systems can lead to the formation of various metabolic products, are easy operate, and can yield products in sufficient amounts for isolation and further study, • candidate metabolites are available in relatively large amounts and can be used to identify the real in vivo metabolites and provide sample for pharmacological testing, • the mode of metabolism can be clarified, for example, unstable metabolites can be isolated under selected and controlled reaction conditions, • the usage of experimental animals can be reduced.
In this review we focus the application of metalloporphyrin-based systems on known drugs, drug candidates and agrochemicals that mimic P450 catalyzed processes. The selection of small molecule substrates was based on a dual criteria:
• despite being a small molecule, has an aromatic ring, an aliphatic ring, and a Ncontaining heterocyclic ring moiety etc., which can be converted by a metabolic process, • data are available on its in vitro and/or in vivo metabolism. IBPP was oxidized by the TPPMnCl -NaOCl-bezalkonium chloride -4'-imidazoylacetophenone (in CH 2 Cl 2 at 0 o C) system to preferentially yield 6,7-epoxide which appeared to be an intermediated of main metabolite, 6,7-dihydro-6,7-diol, in vivo (human) 3 and in vitro, 4 which had not yet been isolated. Because of instability of the 6,7-epoxide in buffer solution, it was difficult to obtain appreciable amounts by dehydration with triphenylphosphine of 6,7-dihydro-6,7-diol. Novel epoxidation of the pyrazolo[1,5-a] pyridine ring was carried out by the chemical model system, metalloporphyrin-NaOCl ( Figure 2 ). The monoepoxide and diepoxide were selectively prepared using TPPMnCl and TF 8 PPFeCl 5 , respectively. 
In the further study, the reaction profiles of IBPP in microsomes and various chemical models (TPPFeCl, TPPMnCl, TF 8 PPFeCl, TOMe 12 PPFeCl, TPh 12 PPFeCl / iodosybenzene (PhIO), NaOCl, m-chloroperbenzoic acid (mCPBA), Pt-colloid/H 2 , O 2 ) were compared. A common reaction product (3-COOH) was obtained in the catalysts/Pt-colloid system and this product was also detected in the rat microsomal system. The α oxidation (2 α-OH, 3 α-OH  and 2,3 α-diOH) of the side chains of IBPP and the ring hydroxylation (6,7-diOH) were the main pathways in both chemical model systems and microsomes. The reaction profile of IBPP in the metalloporphyrin model system was most similar to that in the rat or human microsomal system ( Figure 3 Phencyclidine (PCP, an anesthetic agent) The major in vitro metabolites were identified from human liver microsomes as piperidine-4-hydroxyl and cyclohexane-4-hydroxyl derivatives. 7 TPPFeCl catalyzed oxidation of PCP leads to the production of more of the piperidine ring-3-oxo compound than any other product if either iodosylxylene or cumene hydroperoxide is used as the oxidant (Figure 4 ). This product was quantified as the hydroxyl derivative after reduction by sodium borohydride because the piperidine-3-oxo compound is unstable.
Similarly to in vitro metabolism the TPPFeCl-Zn-acetic acid-O 2 system was found to hydroxylate preferentially the cyclohexane and piperidine rings. Hydroxylation of the aromatic ring was restricted to the meta position. 
Nicotine
The major in vivo metabolites of nicotine in human are cotinine and 3'-hydroxycotinine ( Figure  5 ). 9, 10 In case of TPPFeCl/PhIO system, only one product was obtained, this was shown to be cotinine. When using TPPMnCl as catalyst with PhIO, the yield of cotinine was substantially increased. Cotinine was also oxidized by model systems. The TPPFeCl model only oxidized cotinine to 3-OH cotinine. When using TPPMnCl model, one further product was obtained. MS and NMR data indicated that it is isomeric with the keto-amide, which has been isolated as a urinary metabolite from Rhesus monkey. Acetaminophen (an analgesic and antipyretic drug) N-acetyl-p-quinone-imine (NAPQI), the electrophilic metabolite of acetaminophen responsible for hepatic necrosis and renal damage, is believed to be an enzymatic oxidation product involving cytochrome P450 or/and systems like peroxidase or prostaglandin synthase. 15, 16 As metabolic reactions occur in biologically neutral aqueous medium, it could be more interesting to develop model systems active in physiological conditions. Therefore water-soluble metalloporphyrins and water-soluble oxygen donor (KHSO 5 ) were chosen for model reaction. Four water-soluble metalloporphyrins were tested: they were cationic (TMPyP) or anionic (TSPP) and metallated either by Mn or Fe. The nature of oxidation products of model reaction depends on the time and on the pH of reactions. TPPFeCl appeared as the most efficient catalytic system between pH7 and pH5; decreased activity at pH7 might be attribute to the generation of inactive µ-oxo iron porphyrin dimmers. The TPPMnCl was far less active, and the pH effect was opposite. TMPyPMn was more efficient at pH7, and the iron derivative more active at pH5. In early step of the oxidation, the conversion of acetaminophen to NAPQI is apparently quantitative; then the polymerization process occur, giving nonstoichiometric amounts of NAPQI, 1,4-benzoquinone-monoimine (PQI), 1,4-benzoquinone (BQ) (Fig. 7. ). aromatic ring of lidocaine, mainly catalyzed by P450s of the 1A subfamily, leading to phenol 3 ( Figure 9 ). 21 The oxidation of lidocaine was carried out with various metalloporphyrin model systems TCl 8 PPMnCl, TC 8 PPFeCl, TCl 8 SPPMnCl/ H 2 O 2 , PhIO, magnesium monoperoxyphthalate (MMP). Most model system oxidize lidocaine at its tertiary amine function which is very reactive towards the electrophilic metal-oxo active species. Model systems also give products from: (i) further oxidation of 1; and (ii) combination of 1 with CH 3 CHO and other electrophilic products derived from the oxidation of 1. Oxidation of lidocaine at sites other than its amine function was obtained by performing the reaction in water at acidic pH with an oxidant and a stable Mn porphyrin soluble in water. These conditions lead to the formation of benzylic alcohol 2. Metabolite 3 was never detected in biomimetic reactions. Finally, using metalloporphyrin model systems, metabolites 4, 1 and 2 were prepared in relatively large amounts, which were sufficient to establish their structure. These systems are versatile and may be used in organic solvent and water. A proper choice of their components led to conditions of selective formation of 1,4,5 or 2. Odapipam (a dopamine D-1 receptor antagonist) Four in vitro metabolites of odapipam were isolated from rat liver microsomes; N-desmethylodapipam, 1-hydroxy-odapipam and two isomers of 3'-hydroxy-odapipam.
Oxidation of odapipam was carried out with TF 20 PPFeCl. Cumene hydroperoxide was used as the source of exogenous oxygen. Products of model reaction were revealed complete identity with authentic reference samples of the major metabolites of odapipam previously isolated from urine of rats or characterized from rat liver microsomal incubations. 25 The model reaction has been used to achieved N-demethylation, aliphatic hydroxylation and N-oxidation on odapipam (Figure 10 ). 
Aminopyrine
The major oxidative metabolites of aminopyrine in human are N-formyl-aminopyrine, aminopyrine and N-methylaminopyrine. 27 Oxidation of aminopyrine was carried out with TCl 8 βCl 8 PPFe(SO 3 H) 4 . PhIO was used as the source of exogenous oxygen. Products of model reaction revealed complete identity with authentic reference samples of the major metabolites of aminopyrine previously isolated from urine of rats or characterized from rat liver microsomal incubations. The model reaction has been used to achieved N-demethylation, aliphatic and aromatic hydroxylation and N-oxidation on aminopyrine ( Figure 11 ).
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The N,N-dimethylalkylamine N-oxide 6 was efficiently demethylated using two kind of metalloporphyrins TPPFeCl, TPPMnCl with additives (imidazole, 1,2,4-triazole, tetrazole) to afford the corresponding secondary amine 7 which had been proposed as one of the metabolites of OPC-31260, in the rat, dog and human. 29 The study demonstrated the simple preparation method for secondary amine in high yield from the corresponding N,N-dimethylalkylamine Noxide ( Figure 12 ). Figure 13 ). 31 Different metalloprophyrins were used in non-aqueous TF 20 PPMnCl, TF 20 PPFeCl and aqueous (TF 8 SPPMnCl, TF 8 SPPFeCl) medium in combination with imidazole or pyridine as cocatalysts. Iodosylbenzene was used to compare reaction profile with that of hydrogen peroxide. In the biomimetic systems 11 and its methyl ester were only found in small quantities. This proves the possibility of O-dealkylations with the biomimetic method, but the cleavage of the ether bond is clearly not favoured. The absence of 13 and 14 in the biomimetic reactions are not surprising, because they are products of reductive transformations. Another metabolite 9, discovered in rat and human, was also found in moderate yields. Furthermore, 8 and its methyl ester 10 were obtained in biomimetic studies. From metabolism in rat only 10 and the ethyl ester of 8 are known.
Less than 1% of the applied dose of denaverine hydrochloride could be detected in metabolism studies in human. Besides unchanged denaverine hydrochloride, compounds 9 and 11 were detected. They are generated in chemical model systems, too. Diclofenac (an anti-inflammatory drug) Metabolism of diclofenac in man leads to two hydroxylated products. The major metabolite results from 4′-hydroxylation of diclofenac, which catalyzed by cytochrome P450 2C9. 33 The minor metabolite results from 5-hydroxylation of the most electron-rich aromatic ring of the drug, which is catalyzed by several cytochromes P450, including 3A4, 2C8 and 2C19 ( Figure  14) . 34 Oxidation of diclofenac was carried out with two kind of metalloporphyrins TCl 8 PPMnCl and TCl 8 PPFeCl) in combination with CH 3 COONH 4 as co-catalysts. H 2 O 2 or t-BuOOH were used as the source of exogenous oxygen.
Results showed that the electrophilic species derived from reaction of iron porphyrin with oxygen atom donors regioselectively oxidize diclofenac at position 5. This is not surprising, as position 5 is para to an NH substituent on the more electron-rich aromatic ring of diclofenac and should be the most reactive one towards oxidants. The mechanism of formation of quinone-imine could either involve a N-oxidation of diclofenac with appearance of a cationic or radical species at position 5 within a quinone-imine type species and transfer of an OH group at this position, or Etodolac (an anti-inflammatory agent) The major primary oxidative metabolites of etodolac in man are 6-hydroxyetodolac, 7-hydroxyetodolac and 8-(1′-hydroxy)etodolac, whereas the major metabolite in rat is 4-oxoetodolac ( Figure 15 ). Carbofuran (an insecticide) On the basis of radiolabeling studies, the major metabolite of carbofuran was identified as 3-hydroxycarbofuran, along with N-hydroxymethyl and 7-hydroxy analogues as minor components These compounds can be further transformed to the corresponding 3-keto, 3,7-dihydroxy, and 3-keto-7-hydroxy metabolites before conjugation and excretion ( Figure 16 ). 38 Biomimetic oxidation of carbofuran was firstly carried out using mCPBA, NaOCl, and H 2 O 2 in the presence of TCl 8 PPFeCl. Comparing the results with the metabolite profile measured in houseflies (Musca domestica), we found that in contrast to in vivo experiments, hydrolysis of carbamate side chain took place in all systems. In the case of NaOCl, due to the alkaline medium, this hydrolysis became dominant. In addition to the main product (3-keto-7-hydroxycarbofuran) oxidation at the C3 center yielded the 3-keto metabolite as well. Oxidations associated with the simultaneous hydrolysis of the carbamate group led to the formation of products (3,7-hydroxy and 3-keto-N-hydroxymethyl) derived by multistep transformations.
Oxidation catalyzed by the most popular TF 20 PPFeCl were carried out to improve the performance of our model. Use of mCPBA as oxidant resulted in the almost selective formation of 3-keto-N-hydroxymethyl metabolite. Oxidation with H 2 O 2 , however, reproduced rather well the in vivo profile. Increased resistance of TF 20 PPFeCl against oxidative degradation may be responsible for differences between product distributions observed in TCl 8 PPFeCl-and TF 20 PPFeCl-catalyzed reactions. 
